{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:17:19Z","timestamp":1792649839328,"version":"4.5.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>High-energy trauma with severe bone fractures can be complicated by infection, leading to the development of osteomyelitis. <jats:italic>Pseudomonas aeruginosa<\/jats:italic> is an important causative agent of such infections because of its high virulence profile and ability to develop resistance against a wide range of antimicrobials quickly. <jats:italic>P. aeruginosa<\/jats:italic> biofilms cause treatment failure and relapsing infections. Bacteriophages are viruses that can be used to treat biofilm-associated infections. Moreover, the combination of phages with certain antimicrobials have demonstrated synergistic and additive effects. We present a case of a 21-year-old patient with relapsing multidrug-resistant (MDR) <jats:italic>P. aeruginosa<\/jats:italic> femur osteomyelitis that developed after a road accident, with a proximal right femoral Grade III B open fracture and severe soft tissue damage. Despite extensive antimicrobial treatment and multiple surgical interventions with wound debridement, the infection persisted, with subsequent development of femoral osteomyelitis with a fistula. Patient care management included femoral head excision with wound debridement, intravenous (IV) ceftazidime-avibactam, and the local application of the lytic <jats:italic>Pseudomonas<\/jats:italic> bacteriophage cocktail BFC 1.10. Nine months after the intervention, the patient did not show any clinical, radiological, or laboratory signs of inflammation; therefore, hip replacement was performed. Nevertheless, recurrent <jats:italic>P. aeruginosa<\/jats:italic> infection evolved at the distal side of the femur and was successfully treated with conventional antimicrobials. In this case, wound debridement combined with antibiotics and bacteriophages resulted in bacterial eradication of proximal femoral segment, avoiding leg amputation, but failed to treat osteomyelitis in distal bone segment. An <jats:italic>in vitro<\/jats:italic> assessment of the isolated MDR <jats:italic>P. aeruginosa<\/jats:italic> strain for biofilm formation and phage susceptibility was performed. Additionally, the antimicrobial effects of ceftazidime-avibactam and BFC 1.10 were determined on planktonic cell growth and bacterial biofilm prevention was evaluated. The isolated bacterial strains were susceptible to the bacteriophage cocktail. Strong biofilm formation was detected 6 h after inoculation. Ceftazidime-avibactam combined with BFC 1.10 was most effective in preventing planktonic cell growth and biofilm formation. In both cases, the required concentration of ceftazidime-avibactam decreased two-fold. This study demonstrates the possible use of bacteriophages and antibiotics in difficult-to-treat bone and soft tissue infections, where the additive effects of phages and antibiotics were observed.<\/jats:p>","DOI":"10.3389\/fmed.2022.851310","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T07:55:00Z","timestamp":1650873300000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Use of Phage Cocktail BFC 1.10 in Combination With Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Femur Osteomyelitis\u2014A Case Report"],"prefix":"10.3389","volume":"9","author":[{"given":"Karlis","family":"Racenis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dace","family":"Rezevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monta","family":"Madelane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ervins","family":"Lavrinovics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Djebara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aivars","family":"Petersons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juta","family":"Kroica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2309499017692712","DOI":"10.1177\/2309499017692712","article-title":"Infection after fracture osteosynthesis - Part I","volume":"25","author":"Fang","year":"2017","journal-title":"J Orthop Surg (Hong Kong)."},{"key":"B2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.cmi.2019.08.006","article-title":"Pathogenesis and management of fracture-related infection","volume":"26","author":"Depypere","year":"2020","journal-title":"Clin Microbiol Infect."},{"key":"B3","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.rbo.2016.09.004","article-title":"Infection rate in adult patients with open fractures treated at the emergency hospital and at the ULBRA university hospital in Canoas, Rio Grande do Sul, Brazil","volume":"52","author":"Guerra","year":"2017","journal-title":"Rev Bras Ortop."},{"key":"B4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.12968\/jowc.2017.26.1.20","article-title":"The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data","volume":"26","author":"Malone","year":"2017","journal-title":"J Wound Care."},{"key":"B5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12941-020-00389-5","article-title":"Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review","volume":"19","author":"Chegini","year":"2020","journal-title":"Ann Clin Microbiol Antimicrob."},{"key":"B6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/v11060567","article-title":"Understanding and exploiting phage\u2013host interactions","volume":"11","author":"Stone","year":"2019","journal-title":"Viruses."},{"key":"B7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcimb.2019.00022","article-title":"Fighting pathogenic bacteria on two fronts: phages and antibiotics as combined strategy","volume":"9","author":"Tagliaferri","year":"2019","journal-title":"Front Cell Infect Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e01462","DOI":"10.1128\/mBio.01462-20","article-title":"Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry","volume":"11","author":"Gu Liu","year":"2020","journal-title":"MBio."},{"key":"B9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/v11100891","article-title":"Bacteriophage application for difficult-to-treat musculoskeletal infections: development of a standardized multidisciplinary treatment protocol","volume":"11","author":"Onsea","year":"2019","journal-title":"Viruses"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e00924","DOI":"10.1128\/AAC.00924-19","article-title":"Bacteriophages as adjuvant to antibiotics for the treatment of periprosthetic joint infection caused by multidrug-resistant Pseudomonas aeruginosa","volume":"64","author":"Tkhilaishvili","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41467-021-27656-z","article-title":"Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae","volume":"13","author":"Eskenazi","year":"2022","journal-title":"Nat Commun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3390\/antibiotics9110795","article-title":"The safety and efficacy of phage therapy for bone and joint infections: a systematic review","volume":"9","author":"Clarke","year":"2020","journal-title":"Antibiotics (Basel)."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3390\/v13071268","article-title":"The safety and toxicity of phage therapy: a review of animal and clinical studies","volume":"13","author":"Liu","year":"2021","journal-title":"Viruses."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e4944","DOI":"10.1371\/journal.pone.0004944","article-title":"Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials","volume":"4","author":"Merabishvili","year":"2009","journal-title":"PLoS ONE."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"Association","year":"2013","journal-title":"JAMA."},{"key":"B16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12864-017-3842-z","article-title":"Comparative genome and transcriptome analysis reveals distinctive surface characteristics and unique physiological potentials of Pseudomonas aeruginosa ATCC 27853","volume":"18","author":"Cao","year":"2017","journal-title":"BMC Genomics."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s11095-014-1617-7","article-title":"Quality and safety requirements for sustainable phage therapy products","volume":"32","author":"Pirnay","year":"2015","journal-title":"Pharm Res."},{"key":"B18","first-page":"66","article-title":"Experimental phage therapy of burn wound infection: difficult first steps","volume":"4","author":"Rose","year":"2014","journal-title":"Int J Burns Trauma."},{"key":"B19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13054-017-1709-y","article-title":"Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury\u2014a case report","volume":"21","author":"Jennes","year":"2017","journal-title":"Critical Care."},{"key":"B20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3390\/antibiotics9090582","article-title":"S. aureus colonization, biofilm production, and phage susceptibility in peritoneal dialysis patients","volume":"9","author":"Racenis","year":"2020","journal-title":"Antibiotics."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1128\/JCM.37.6.1771-1776.1999","article-title":"The Calgary Biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms","volume":"37","author":"Ceri","year":"1999","journal-title":"J Clin Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ijantimicag.2012.04.006","article-title":"In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients","volume":"40","author":"Fern\u00e1ndez-Olmos","year":"2012","journal-title":"Int J Antimicrob Agents."},{"key":"B23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2180-5-53","article-title":"High-throughput metal susceptibility testing of microbial biofilms","volume":"5","author":"Harrison","year":"2005","journal-title":"BMC Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2106\/JBJS.N.01350","article-title":"Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009","volume":"97","author":"Kremers","year":"2015","journal-title":"J Bone Joint Surg Am."},{"key":"B25","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/00005373-198408000-00009","article-title":"Problems in the management of type III (severe) open fractures: a new classification of type III open fractures","volume":"24","author":"Gustilo","year":"1984","journal-title":"J Trauma."},{"key":"B26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/jcm8050673","article-title":"The Different microbial etiology of prosthetic joint infections according to route of acquisition and time after prosthesis implantation, including the role of multidrug-resistant organisms","volume":"8","author":"Benito","year":"2019","journal-title":"J Clin Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.5435\/JAAOS-D-18-00193","article-title":"Antibiotic prophylaxis in open fractures: evidence, evolving issues, and recommendations","volume":"28","author":"Garner","year":"2020","journal-title":"J Am Acad Orthop Surg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1089\/sur.2019.140","article-title":"Open fractures: are we still treating the same types of infections?","volume":"21","author":"Sudduth","year":"2020","journal-title":"Surg Infect (Larchmt)."},{"key":"B29","doi-asserted-by":"publisher","first-page":"513242","DOI":"10.3389\/fmed.2020.513242","article-title":"Implant-associated bone and joint infections: experience in a Regional Reference Center in France","volume":"7","author":"Cerioli","year":"2020","journal-title":"Front Med (Lausanne)."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/jac\/dkg186","article-title":"Risk factors and treatment outcomes in osteomyelitis","volume":"51","author":"Tice","year":"2003","journal-title":"J Antimicrob Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fcimb.2019.00182","article-title":"Repair process impairment by","volume":"9","author":"Ruffin","year":"2019","journal-title":"Front Cell Infect Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.3390\/ijms21228671","article-title":"Pseudomonas aeruginosa biofilms","volume":"21","author":"Thi","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0169565","DOI":"10.1371\/journal.pone.0169565","article-title":"Bad to the bone: on in vitro and ex vivo microbial biofilm ability to directly destroy colonized bone surfaces without participation of host immunity or osteoclastogenesis","volume":"12","author":"Junka","year":"2017","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2174\/1874285801711010053","article-title":"Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents","volume":"11","author":"Singh","year":"2017","journal-title":"Open Microbiol J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jgar.2019.12.009","article-title":"Resistance to ceftazidime-avibactam and underlying mechanisms","volume":"22","author":"Wang","year":"2020","journal-title":"J Glob Antimicrob Resist."},{"key":"B36","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1128\/JVI.00385-15","article-title":"Phage therapy: a step forward in the treatment of Pseudomonas aeruginosa infections","volume":"89","author":"Pires","year":"2015","journal-title":"J Virol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1021\/acsinfecdis.1c00117","article-title":"Synergistic effects of phage-antibiotic combinations against","volume":"8","author":"Manohar","year":"2022","journal-title":"ACS Infect Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/emph\/eoy005","article-title":"Phage treatment of an aortic graft infected with","volume":"2018","author":"Chan","year":"2018","journal-title":"Evol Med Public Health."},{"key":"B39","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fmed.2020.00342","article-title":"The potential innovative use of bacteriophages within the DAC","volume":"7","author":"Ferry","year":"2020","journal-title":"Front Med (Lausanne)."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.851310\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T07:55:03Z","timestamp":1650873303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.851310\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":39,"alternative-id":["10.3389\/fmed.2022.851310"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.851310","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"article-number":"851310"}}